INVESTMENT ADVISORY SERVICES INC /TX /ADV
Position in ABBV — AbbVie Inc.
CIK 925953
THE WOODLANDS, TX
Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$6,221,044
+$853,174 QoQ
Shares Held
24,722
+0.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.07%
of 13F equity value
Holder Rank
#1,182
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INVESTMENT ADVISORY SERVICES INC /TX /ADV holds $16,555,030 across 7 Drug Manufacturers - General names. ABBV ranks #2 (37.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,036 | $6,612,362 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
24,722 | $6,221,044 | |
| 3 | AMGN |
Amgen Inc
|
5,246 | $1,899,681 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,465 | $959,252 | |
| 5 | LLY |
ELI LILLY & Co
|
296 | $355,031 | |
| 6 | PFE |
Pfizer Inc
|
12,058 | $290,356 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,720 | $217,304 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,221,044 | 24,722 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $5,367,870 | 24,681 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $5,792,221 | 25,350 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $5,908,900 | 25,520 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $4,806,629 | 25,895 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $5,235,485 | 24,988 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $4,588,391 | 25,821 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $5,630,154 | 28,510 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $5,213,693 | 30,397 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $5,715,936 | 31,389 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $4,918,127 | 31,736 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $4,762,616 | 31,951 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $4,301,389 | 31,926 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,087,409 | 31,922 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $5,197,862 | 32,163 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $4,299,551 | 32,036 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,900,507 | 31,996 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $5,290,784 | 32,637 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $4,405,103 | 32,534 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,459,714 | 32,073 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $3,618,785 | 32,127 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $3,529,628 | 32,941 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $2,889,331 | 32,987 | Shares | Sole | 2021-03-10 | |
| 2020-06-30 | $3,228,649 | 32,885 | Shares | Sole | 2021-03-10 | |
| 2020-03-31 | $2,302,842 | 30,225 | Shares | Sole | 2021-03-10 | |
| No filing history on record for this holder in this stock. | ||||||